4//SEC Filing
Banham John Michael Middlecott 4
Accession 0001104659-13-044379
CIK 0001130166other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:32 PM ET
Size
5.6 KB
Accession
0001104659-13-044379
Insider Transaction Report
Form 4
Banham John Michael Middlecott
Director
Transactions
- Award
Option
2013-05-22+5,000→ 5,000 totalExercise: $2.99Exp: 2023-05-22→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.
- [F2]These options were granted to Sir Banham for his services as chairman of the Audit Committee of the board of directors of Cyclacel Pharmaceuticals, Inc.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357635
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:32 PM ET
- Size
- 5.6 KB